Tenet Healthcare Price Target Raised to $168.00/Share From $112.00 by Cantor Fitzgerald
Tenet Healthcare Analyst Ratings
Truist Financial Maintains Tenet Healthcare(THC.US) With Buy Rating, Raises Target Price to $170
Truist Raises Price Target on Tenet Healthcare to $170 From $155, Keeps Buy Rating
Analysts Offer Insights on Healthcare Companies: Edwards Lifesciences (EW) and Tenet Healthcare (THC)
Citi Maintains Tenet Healthcare(THC.US) With Buy Rating, Raises Target Price to $171
Tenet Healthcare (THC) Receives a Buy From Citi
Goldman Sachs Maintains Tenet Healthcare(THC.US) With Buy Rating
Tenet Healthcare's Strong Q2 Performance and Upward Guidance Justify Buy Rating
Tenet Healthcare Analyst Ratings
Tenet Healthcare Analyst Ratings
Barclays Sticks to Its Buy Rating for Tenet Healthcare (THC)
Tenet Healthcare Analyst Ratings
Tenet Healthcare Analyst Ratings
Tenet Healthcare Analyst Ratings
Tenet Healthcare Analyst Ratings
Tenet Healthcare Analyst Ratings
Analysts Offer Insights on Healthcare Companies: Pliant Therapeutics (PLRX) and Tenet Healthcare (THC)
Analysts Offer Insights on Healthcare Companies: Inmune Bio (INMB), Insmed (INSM) and Tenet Healthcare (THC)
Tenet Healthcare Analyst Ratings
No Data